Iris Löw-Friedrich
Chief Executive Officer chez ZOGENIX, INC.
Profil
Le Dr Iris Lw-Friedrich est vice-présidente du conseil de surveillance d'Evotec SE, Chief Medical Officer et Executive Vice President d'UCB SA et professeur à l'université Johann Wolfgang Goethe de Francfort-sur-le-Main. Elle est membre du conseil d'administration de Fresenius SE & Co. KGaA et Evotec SE. Auparavant, le Dr Lw-Friedrich a été employée en tant que présidente de Transcelerate Biopharma, Inc, membre du conseil de surveillance de Heidelberg Pharma AG, directrice de la recherche et du développement d'UCB Pharma GmbH, vice-présidente des projets mondiaux de BASF Pharma, vice-présidente des projets mondiaux de BASF AG, vice-présidente du développement clinique de Hoechst AG, responsable de la gestion clinique mondiale et vice-présidente d'Aventis Pharma AG, et vice-présidente du développement clinique de Hoechst Marion Roussel, Inc. Elle a obtenu son doctorat à l'université Johann Wolfgang Goethe de Francfort-sur-le-Main.
Postes actifs de Iris Löw-Friedrich
Sociétés | Poste | Début |
---|---|---|
UCB | Chief Tech/Sci/R&D Officer | 01/03/2008 |
EVOTEC SE | Chairman | 15/06/2021 |
FRESENIUS SE & CO. KGAA | Director/Board Member | 13/05/2016 |
ZOGENIX, INC. | Chief Executive Officer | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main | Corporate Officer/Principal | 01/01/2000 |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Director/Board Member | 01/04/2019 |
Anciens postes connus de Iris Löw-Friedrich
Sociétés | Poste | Fin |
---|---|---|
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Chairman | 01/09/2017 |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Chief Tech/Sci/R&D Officer | 01/01/2009 |
BASF SE | Corporate Officer/Principal | 01/01/2001 |
░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Iris Löw-Friedrich
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
FRESENIUS SE & CO. KGAA | Health Technology |
BASF SE | Process Industries |
UCB | Health Technology |
EVOTEC SE | Health Technology |
HEIDELBERG PHARMA AG | Health Technology |
Entreprise privées | 8 |
---|---|
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Aventis Pharma AG | |
Hoechst Marion Roussel, Inc. | |
BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Commercial Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |